Aerva lanata is a prostrate under-shrub used as traditional and modern system of
medicine. The Prime of current study was to compare the antiproliferative and antioxidant
potential of in vitro and in vivo leaf and callus extracts of Aerva lanata against human breast
cancer (MCF 7) cell lines. Anticancer proficiency of methanol extracts of in vitro and in vivo leaf
and matured callus extracts were evaluated by 3 - (4, 5 – dimethylthiazole – 2 – yl) - 2, 5 -diphenyl
tetrazolium bromide (MTT) and DNA fragmentation assays. Earlier the total antioxidant potential of the different solvent
extracts was tested by 2, 2' – azino – bis (3-ethylbenzthiazoline – 6 – sulphonic acid (ABTS) assay. A dose dependent
inhibition of cancer cell proliferation was identified in MTT assay. Further, DNA fragmentation assay was performed and
the results show the best IC50 values produced best possible digestion of DNA (by apoptosis). The results of radical
scavenging activity of ABTS cation assay was recorded promising inhibitory effects of callus, in vivo and in vitro leaf
methanol extracts. The inhibition rate was mainly dependent on concentration of extracts. Total phenols, tannins and
flavonoids contents of the test samples were quantified. The overall results from the study highlights the use of least
concentrations of methanolic callus extracts of plant has potential use in treatment of cancer related diseases in future.
Keywords: ABT’S, Aerva lanata, Callus, DNA fragmentation, MCF – 7, MTT.
Rights & PermissionsPrintExport